Ritholtz Wealth Management Novo Nordisk A S Transaction History

Ritholtz Wealth Management

$3.29 Billion
Q1 2025

A detailed history of Ritholtz Wealth Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Ritholtz Wealth Management holds 104,309 shares of NVO stock, worth $6.93 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

104,309

Previous 120,826 13.67%

Holding current value

$6.93 Million

Previous $10.4 Million 30.31%

% of portfolio

0.22%

Previous 0.31%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 16, 2025	SELL	$69.3 - $90.95 $1.14 Million - $1.5 Million	-16,517 Reduced 13.67%	104,309 $7.24 Million
Q4 2024 Jan 14, 2025	BUY	$85.0 - $120.04 $198,985 - $281,013	2,341 Added 1.98%	120,826 $10.4 Million
Q3 2024 Oct 10, 2024	BUY	$119.07 - $145.42 $1.06 Million - $1.3 Million	8,934 Added 8.16%	118,485 $14.1 Million
Q2 2024 Jul 31, 2024	BUY	$122.71 - $146.91 $91,296 - $109,301	744 Added 0.68%	109,551 $15.6 Million
Q1 2024 Apr 24, 2024	BUY	$102.11 - $135.92 $2.48 Million - $3.3 Million	24,289 Added 28.74%	108,807 $14 Million
Q4 2023 Jan 18, 2024	BUY	$87.78 - $105.45 $227,789 - $273,642	2,595 Added 3.17%	84,518 $8.74 Million
Q3 2023 Oct 13, 2023	BUY	$90.94 - $199.54 $2.96 Million - $6.5 Million	32,563 Added 65.97%	81,923 $7.45 Million
Q2 2023 Jul 14, 2023	BUY	$155.98 - $172.65 $115,425 - $127,761	740 Added 1.52%	49,360 $7.99 Million
Q1 2023 Apr 19, 2023	BUY	$132.34 - $159.14 $319,336 - $384,004	2,413 Added 5.22%	48,620 $7.74 Million
Q4 2022 Jan 18, 2023	BUY	$102.55 - $135.33 $1.13 Million - $1.49 Million	11,020 Added 31.32%	46,207 $0
Q3 2022 Oct 18, 2022	BUY	$95.28 - $116.93 $542,619 - $665,916	5,695 Added 19.31%	35,187 $3.51 Million
Q2 2022 Jul 15, 2022	BUY	$103.24 - $121.81 $496,997 - $586,393	4,814 Added 19.51%	29,492 $3.29 Million
Q1 2022 Apr 14, 2022	BUY	$93.1 - $112.54 $565,861 - $684,018	6,078 Added 32.68%	24,678 $2.74 Million
Q4 2021 Jan 18, 2022	BUY	$95.88 - $117.08 $330,402 - $403,457	3,446 Added 22.74%	18,600 $2.08 Million
Q3 2021 Oct 14, 2021	BUY	$84.42 - $106.62 $204,887 - $258,766	2,427 Added 19.07%	15,154 $1.46 Million
Q2 2021 Jul 20, 2021	BUY	$67.66 - $84.76 $198,514 - $248,685	2,934 Added 29.96%	12,727 $1.07 Million
Q1 2021 May 12, 2021	BUY	$67.06 - $75.82 $210,769 - $238,302	3,143 Added 47.26%	9,793 $660,000
Q4 2020 Jan 19, 2021	BUY	$63.89 - $73.8 $43,700 - $50,479	684 Added 11.46%	6,650 $465,000
Q3 2020 Oct 23, 2020	BUY	$63.69 - $70.22 $93,815 - $103,434	1,473 Added 32.78%	5,966 $414,000
Q2 2020 Jul 15, 2020	BUY	$58.54 - $67.94 $263,020 - $305,254	4,493 New	4,493 $294,000

Others Institutions Holding NVO

# of Institutions

1,849

Shares Held

339M

Call Options Held

12M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $150B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ritholtz Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Ritholtz Wealth Management with notifications on news.

Account

Ritholtz Wealth Management Novo Nordisk A S Transaction History